Quarterly report pursuant to Section 13 or 15(d)

Contingencies and commitments - Universal Cells Research, Collaboration and License Agreement and Co-development and Co-commercialization agreement (Details)

v3.23.1
Contingencies and commitments - Universal Cells Research, Collaboration and License Agreement and Co-development and Co-commercialization agreement (Details) - Collaboration and license agreement - Universal Cells, Inc. - USD ($)
1 Months Ended 12 Months Ended
Feb. 29, 2016
Nov. 30, 2015
Dec. 31, 2018
Dec. 31, 2017
Mar. 31, 2023
Dec. 31, 2022
Contingencies and commitments            
Upfront license and start-up fees   $ 2,500,000        
Milestone payments $ 3,000,000   $ 200,000 $ 900,000    
First milestone payment           $ 500,000
Second milestone payment           600,000
Third milestone payment           $ 400,000
Milestone payment accrued but not yet paid         $ 1,800,000